Skip to main content

Enfortumab vedotin

Generic name: enfortumab vedotin [ en-FORT-ue-mab-ve-DOE-tin ]
Brand name: Padcev
Dosage form: intravenous powder for injection (ejfv 20 mg; ejfv 30 mg)
Drug class: Miscellaneous antineoplastics

Medically reviewed by Drugs.com on Oct 2, 2023. Written by Cerner Multum.

What is enfortumab vedotin?

Enfortumab vedotin is used to treat cancer of the bladder or urinary tract that has spread to other parts of the body (metastatic), or cannot be removed with surgery.

Enfortumab vedotin is usually given after other treatments such as immunotherapy and platinum cancer medicine, or if you are unable to receive platinum cancer medicine.

Enfortumab vedotin may also be used for purposes not listed in this medication guide.

Enfortumab vedotin side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

enfortumab vedotin can cause a severe or life-threatening skin rash. Get emergency medical help if you have a worsening rash with itching, blistering, peeling, skin lesions that look like rings, a fever or flu-like symptoms, swollen glands, or painful sores in your mouth, nose, throat, or genital area.

Call your doctor at once if you have symptoms of high blood sugar:

Also call your doctor at once if you have:

Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.

Common side effects of enfortumab vedotin may include:

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Warnings

This medicine can cause a severe or life-threatening skin rash. Get emergency medical help if you have a worsening rash with itching, blistering, peeling, skin lesions that look like rings, a fever or flu-like symptoms, swollen glands, or painful sores in your mouth, nose, throat, or genital area.

Before taking this medicine

Tell your doctor if you have ever had:

Enfortumab vedotin can harm an unborn baby if the mother or the father is using enfortumab vedotin.

Do not breastfeed while using this medicine, and for at least 3 weeks after your last dose.

How is enfortumab vedotin given?

Enfortumab vedotin is injected into a vein by a healthcare provider.

This medicine must be given slowly over 30 minutes.

Tell your medical caregivers if you feel any burning or pain when enfortumab vedotin is injected.

Enfortumab vedotin is given in a 28-day treatment cycle. You will receive an injection only on certain days of this cycle. Your doctor will determine how many cycles you need.

This medicine can cause a severe or life-threatening skin rash, especially during the first treatment cycle. Call your doctor right away if you have a new skin rash with itching that gets worse.

Enfortumab vedotin can cause high blood sugar (hyperglycemia) even if you have never had it before or if you are not diabetic. Severe hyperglycemia may be life-threatening. Your blood sugar may need to be checked often.

Enfortumab vedotin can also cause dry eyes. Your doctor may tell you to use artificial-tear eye drops to help prevent dry eyes.

Enfortumab vedotin dosing information

Usual Adult Dose for Urothelial Carcinoma:

1.25 mg/kg (up to a maximum of 125 mg for patients weighing 100 kg or greater) IV over 30 minutes on Days 1, 8, and 15 of a 28-day cycle

Duration: Until disease progression or unacceptable toxicity.

Comment:
-Combination therapy with pembrolizumab is approved under accelerated approval based on tumor response rate and durability of response.

Use:
For the treatment of adult patients with locally advanced or metastatic urothelial cancer (mUC) who:
-have previously received a programmed death receptor-1 (PD-1) or programmed death-ligand 1 (PD-L1) inhibitor, and a platinum-containing chemotherapy
-are ineligible for cisplatin-containing chemotherapy and have previously received one or more prior lines of therapy

In combination with pembrolizumab, for the treatment of adult patients with locally advanced or metastatic urothelial cancer who are not eligible for cisplatin-containing chemotherapy

What happens if I miss a dose?

Call your doctor for instructions if you miss an appointment for your enfortumab vedotin injection.

What happens if I overdose?

In a medical setting an overdose would be treated quickly.

What should I avoid while receiving enfortumab vedotin?

Follow your doctor's instructions about any restrictions on food, beverages, or activity.

What other drugs will affect enfortumab vedotin?

Many drugs can affect your blood levels of enfortumab vedotin, which may increase side effects. Tell your doctor about all your other medicines, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed here.

Further information

Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.